LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 47 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969 | +10.0% | 245,342 | -12.9% | 0.00% | +100.0% |
| Q2 2023 | $881 | +6.4% | 281,574 | +54.1% | 0.00% | 0.0% |
| Q1 2023 | $828 | -12.4% | 182,742 | -20.1% | 0.00% | 0.0% |
| Q4 2022 | $945 | -99.9% | 228,774 | -22.8% | 0.00% | 0.0% |
| Q3 2022 | $948,000 | +175.6% | 296,367 | +68.8% | 0.00% | – |
| Q2 2022 | $344,000 | -50.9% | 175,542 | +1.6% | 0.00% | -100.0% |
| Q1 2022 | $700,000 | -66.3% | 172,742 | -10.4% | 0.00% | -66.7% |
| Q4 2021 | $2,080,000 | -26.8% | 192,774 | -21.7% | 0.00% | -25.0% |
| Q3 2021 | $2,840,000 | +47.7% | 246,274 | +25.8% | 0.00% | +100.0% |
| Q2 2021 | $1,923,000 | -38.0% | 195,774 | -7.9% | 0.00% | -50.0% |
| Q1 2021 | $3,104,000 | -34.5% | 212,474 | -4.0% | 0.00% | -20.0% |
| Q4 2020 | $4,740,000 | +57.0% | 221,374 | +11.2% | 0.01% | +66.7% |
| Q3 2020 | $3,020,000 | +12.7% | 199,074 | -4.6% | 0.00% | +50.0% |
| Q2 2020 | $2,680,000 | – | 208,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,415,148 | $10,928,000 | 2.94% |
| Opaleye Management Inc. | 1,661,784 | $5,318,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $54,212,000 | 1.08% |
| GREAT POINT PARTNERS LLC | 1,135,000 | $3,632,000 | 0.88% |
| DAFNA Capital Management LLC | 574,996 | $1,840,000 | 0.50% |
| COMMODORE CAPITAL LP | 750,000 | $2,400,000 | 0.39% |
| Altium Capital Management LP | 320,000 | $1,024,000 | 0.38% |
| Atlas Venture Advisors, Inc. | 292,184 | $935,000 | 0.34% |
| Fi3 FINANCIAL ADVISORS, LLC | 99,570 | $319,000 | 0.29% |
| Perceptive Advisors | 2,860,000 | $9,152,000 | 0.27% |